What We Do
We develop novel therapeutics to dramatically improve outcomes for cancer patients, using world-leading innovation in p27 biology
Featured In
01
Many startups are built off research, so why don’t more scientists become founders?
02
CDK Inhibitors: Why Women – and Men – Should Know About
This ‘New Era’ Of Cancer Treatment
03
The academic to founder pipeline with Dr. Stacy Blain from
Concarlo Therapeutics
04
FORCE Family: Opportunity to Join the Fight Against Metastatic Breast Cancer
05
FORCE Family:
Cancer Moonshoot Webinar
06
Drug Discovery World: US Biotech Start-up Set to Have Huge Impact on Breast Cancer Treatment Landscape
07
BioCentury: Concarlo: Targeting proliferation
and resistance in one go
Awards
“The reward for work well done is the opportunity to do more”
—Jonas Salk
The 50 Most admired companies: CIO Bio
Top 100 entreprenuers: Alumni List
Top Biotech Startup 2022
Awarded by: Life Sciences Review
